Ultrasound Imaging in Acute and Chronic Kidney Disease

Editor(s): Meola, M. (Pisa)
Petrucci, I. (Pisa)
Ronco, C. (Vicenza)

Chronic Kidney Disease

Imaging in Chronic Kidney Disease

Meola M.a, b · Samoni S.a, c · Petrucci I.a, b

Author affiliations

aSant'Anna School of Advanced Studies, Pisa, bDepartment of Internal Medicine, University of Pisa, Pisa, and cDepartment of Nephrology Dialysis and Transplantation, International Renal Research Institute (IRRIV), San Bortolo Hospital, Vicenza, Italy

Related Articles for ""
Meola M, Petrucci I, Ronco C (eds): Ultrasound Imaging in Acute and Chronic Kidney Disease. Contrib Nephrol. Basel, Karger, 2016, vol 188, pp 69-80
https://doi.org/10.1159/000445469

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Chronic Kidney Disease

Published online: May 12, 2016
Cover Date: 2016

Number of Print Pages: 12
Number of Figures: 4
Number of Tables: 3

ISBN: 978-3-318-05883-3 (Print)
eISBN: 978-3-318-05884-0 (Online)

Abstract

Chronic kidney disease (CKD) diagnosis and staging are based on estimated or calculated glomerular filtration rate (GFR), urinalysis and kidney structure at renal imaging techniques. Ultrasound (US) has a key role in evaluating both morphological changes (by means of B-Mode) and patterns of vascularization (by means of color-Doppler and contrast-enhanced US), thus contributing to CKD diagnosis and to the follow-up of its progression. In CKD, conventional US allows measuring longitudinal diameter and cortical thickness and evaluating renal echogenicity and urinary tract status. Maximum renal length is usually considered a morphological marker of CKD, as it decreases contemporarily to GFR, and should be systematically recorded in US reports. More recently, it has been found to be a significant correlation of both renal longitudinal diameter and cortical thickness with renal function. Conventional US should be integrated by color Doppler, which shows parenchymal perfusion and patency of veins and arteries, and by spectral Doppler, which is crucial for the diagnosis of renal artery stenosis and provides important information about intrarenal microcirculation. Different values of renal resistive indexes (RIs) have been associated with different primary diseases, as they reflect vascular compliance. Since RIs significantly correlate with renal function, they have been proposed to be independent risk factors for CKD progression, besides proteinuria, low GFR and arterial hypertension. Despite several new applications, US and color Doppler contribute to a definite diagnosis in <50% of cases of CKD, because of the lack of specific US patterns, especially in cases of advanced CKD. However, US is useful to evaluate CKD progression and to screen patients at risk for CKD. The indications and the recommended frequency of color Doppler US could differ in each case and the follow-up should be tailored.

© 2016 S. Karger AG, Basel



Related Articles:

References

  1. Eknoyan G, Levin NW: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 suppl 1):S1-S266.
  2. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 2005;67:2089-2100.
  3. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: Clinical guidelines national kidney foundation practice guidelines for chronic kidney: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147.
  4. Levey AS, Schoolwerth AC, Burrows NR, Williams DE, Stith KR, McClellan W: Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the centers for disease control and prevention. Am J Kidney Dis 2009;53:522-535.
  5. Go AS, Chertow GM, Fan D, Mcculloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
  6. Di Lullo L, House A, Gorini A, Santoboni A, Russo D, Ronco C: Chronic kidney disease and cardiovascular complications. Heart Fail Rev 2015;20:259-272.
  7. US Renal Data System: 2015 Annual Data Report. Volume 2: End-Stage Renal Disease in the United States.
  8. Kooiman J, Pasha SM, Zondag W, Sijpkens YW, van der Molen AJ, Huisman MV, Dekkers OM: Meta-analysis: serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol 2012;81:2554-2561.
  9. Emamian SA, Nielsen MB, Pedersen JF, Ytte L: Kidney dimensions at sonography: correlation with age, sex, and habitus in 665 adult volunteers. AJR Am J Roentgenol 1993;160:83-86.
  10. American College of Radiology (in collaboration with the American Institute of Ultrasound in Medicine AIUM): ACR practice guideline for the performance of an ultrasound examination of the abdomen and/or retro-peritoneum. http://www.acr.org/guidelines.
  11. Van Den Noortgate N, Velghe A, Petrovic M, Vandewiele C, Lameire N, Voet D, Afschrift M: The role of ultrasonography in the assessment of renal function in the elderly. J Nephrol 2003;16:658-662.
  12. Bakker J, Olree M, Kaatee R, de Lange EE, Moons KG, Beutler JJ, Beek FJ: Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging. Radiology 1999;211:623-628.
  13. Sanusi AA, Arogundade FA, Famurewa OC, Akintomide AO, Soyinka FO, Ojo OE, Akinsola A: Relationship of ultrasonographically determined kidney volume with measured GFR, calculated creatinine clearance and other parameters in chronic kidney disease (CKD). Nephrol Dial Transplant 2009;24:1690-1694.
  14. Sugiura T, Nakamori A, Wada A, Fukuhara Y: Evaluation of tubulointerstitial injury by Doppler ultrasonography in glomerular diseases. Clin Nephrol 2004;61:119-126.
  15. Moghazi S, Jones E, Schroepple J, Arya K, Mcclellan W, Hennigar RA, O'Neill WC: Correlation of renal histopathology with sonographic findings. Kidney Int 2005;67:1515-1520.
  16. Beland MD, Walle NL, Machan JT, Cronan JJ: Renal cortical thickness measured at ultrasound: is it better than renal length as an indicator of renal function in chronic kidney disease? AJR Am J Roentgenol 2010;195:W146-W149.
  17. Khati NJ, Hill MC, Kimmel PL: The role of ultrasound in renal insufficiency: the essentials. Ultrasound Q 2005;21:227-244.
  18. Takata T, Koda M, Sugihara T, Sugihara S, Okamoto T, Miyoshi K, Hodotsuka M, Fujise Y, Matono T, Okano J, Hosho K, Iyama T, Fukui T, Fukuda S, Munemura C, Isomoto H: Left renal cortical thickness measured by ultrasound can predict early progression of chronic kidney disease. Nephron 2016;132:25-32.
  19. Bude RO, Rubin JM: Experimental studies relationship between the resistive index and vascular compliance and resistance. Radiology 1999;211:411-417.
  20. Calabia J, Torguet P, Garcia I, Martin N, Mate G, Marin A, Molina C, Valles M: The relationship between renal resistive index, arterial stiffness, and atherosclerotic burden: the link between macrocirculation and microcirculation. J Clin Hypertens (Greenwich) 2014;16:186-191.
  21. Boddi M, Cecioni I, Poggesi L, Fiorentino F, Olianti K, Berardino S, La Cava G, Gensini G: Renal resistive index early detects chronic tubulointerstitial nephropathy in normo- and hypertensive patients. Am J Nephrol 2006;26:16-21.
  22. Parolini C, Noce A, Staffolani E, Giarrizzo GF, Costanzi S, Splendiani G: Renal resistive index and long-term outcome in chronic nephropathies. Radiology 2009;252:888-896.
  23. Radermacher J, Mengel M, Ellis S, Stuht S, Hiss M, Schwarz A, Eisenberger U, Burg M, Luft FC, Gwinner W, Haller H: The renal arterial resistance index and renal allograft survival. N Engl J Med 2003;349:115-124.
  24. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel Mj, Galanski M, Koch Km, Haller H: Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001;344:410-417.
  25. Sugiura T, Wada A: Resistive index predicts renal prognosis in chronic kidney disease: results of a 4-year follow-up. Clin Exp Nephrol 2011;15:114-120.

Article / Publication Details

First-Page Preview
Abstract of Chronic Kidney Disease

Published online: May 12, 2016
Cover Date: 2016

Number of Print Pages: 12
Number of Figures: 4
Number of Tables: 3

ISBN: 978-3-318-05883-3 (Print)
eISBN: 978-3-318-05884-0 (Online)

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

Table of Contents

Article

Recommend This
TOP